- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Curasight AS (CURAS)
Assess today's live Curasight AS (CURAS) share price, performance and insights using our live Spotlight: CURAS stock exchange data.
Analyse the historical data and Curasight AS share price performance charts on this page. Our technical summary section provides analysis on Curasight AS share price buy/sell indicators using real-time data (or discuss the Curasight AS (CURAS) stock price today with other investors in the Curasight AS TE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TE CURAS share price (ISIN: DK0061295797) to enhance your trading decisions with our free investment tools and resources.
What Is the Curasight AS Share Price Today?
The Curasight AS share price today is 14.30.
What Is the Stock Symbol for Curasight AS
The stock symbol (or 'ticker') for Curasight AS is "CURAS."
What Stock Exchange Does Curasight AS Trade On?
Curasight AS is listed and trades on the Spotlight stock exchange.
Is Curasight AS a Good Stock to Buy?
Determining whether Curasight AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Curasight AS share price performance charts on this page. Our technical summary section provides analysis on Curasight AS share price buy/sell indicators using real-time data (or discuss the Curasight AS (CURAS) stock price today with other investors in the Curasight AS TE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TE CURAS share price (ISIN: DK0061295797) to enhance your trading decisions with our free investment tools and resources.
What Is the Curasight AS Share Price Today?
The Curasight AS share price today is 14.30.
What Is the Stock Symbol for Curasight AS
The stock symbol (or 'ticker') for Curasight AS is "CURAS."
What Stock Exchange Does Curasight AS Trade On?
Curasight AS is listed and trades on the Spotlight stock exchange.
Is Curasight AS a Good Stock to Buy?
Determining whether Curasight AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Spotlight
Currency in DKK
14.30
+0.30(+2.14%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.10
14.60
52 wk Range
1.80
17.85
CURAS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.1014.60
52 wk Range
1.8017.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CURAS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
24/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare CURAS to Peers and Sector
Metrics to compare | CURAS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCURASPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.0x | −4.1x | −0.5x | |
PEG Ratio | −0.35 | −0.08 | 0.00 | |
Price/Book | 38.6x | 2.2x | 2.6x | |
Price / LTM Sales | - | 42.7x | 3.2x | |
Upside (Analyst Target) | −44.1% | 82.3% | 48.1% | |
Fair Value Upside | Unlock | 13.9% | 6.6% | Unlock |
Curasight A/S develops therapeutic and diagnostic solutions for the treatment of cancer. The company develops uTREAT therapeutic solutions, that are in Phase IIb clinical trials to treat glioblastoma, non-small cell lung cancers, neuroendocrine neoplasms, head and neck cancer, and pancreatic cancers. It is also developing uTRACE diagnostic solutions, which have completed Phase II clinical trial for the treatment of glioblastoma, prostate cancer, neuroendocrine neoplasms, head and neck cancer, breast cancer, and urinary bladder cancer; and is in Phase II clinical trials to treat non-small cell lung cancer. The company was incorporated in 2013 and is based in Copenhagen, Denmark.
FAQ
What Is the Curasight AS (Spotlight: CURAS) Share Price Today?
The Curasight AS stock price today is 14.30 DKK.
What Stock Exchange Does Curasight AS (CURAS) Trade On?
Curasight AS is listed and trades on the Spotlight Stock Market.
What Is the Ticker (Stock Symbol) for Curasight AS?
The stock symbol (also called a 'ticker') for Curasight AS is "CURAS."
What Is the Current Curasight AS Market Capitalisation?
As of today, Curasight AS (Spotlight: CURAS) market cap is 691.44M DKK.
What Is Curasight AS's (CURAS) Earnings Per Share (TTM)?
The Curasight AS EPS is currently -1.10 (Trailing Twelve Months).
When Is the Next Curasight AS Earnings Date?
Curasight AS's next earnings report will be released on 24/04/2026.
Is CURAS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Curasight AS moving averages and other technical indicators, the daily buy/sell signal for CURAS stock is Strong Sell.
How Many Times Has Curasight AS Stock Split?
Curasight AS has split 0 times. (See the CURAS stock split history page for full effective split date and price information.)
How Many Employees Does Curasight AS Have?
Curasight AS has 4 employees, based on their latest Companies House report.
What is the current trading status of Curasight AS (Spotlight: CURAS)?
As of 03/05/2026, Curasight AS (CURAS) is trading at a share price of 14.30 DKK, with a previous close of 14.00 DKK. The stock has fluctuated within a day range of 14.10 DKK to 14.60 DKK, while its 52-week range spans from 1.80 DKK to 17.85 DKK.
What Is Curasight AS (CURAS) Price Target According to Analysts?
The average 12-month price target for Curasight AS is 8.00 DKK, with a high estimate of 8 DKK and a low estimate of 8 DKK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -44.06% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.